TY - JOUR
T1 - Impact of maternal fructose intake on liver stem/progenitor cells in offspring
T2 - Insights into developmental origins of health and disease
AU - Ando, Yoshitaka
AU - Munetsuna, Eiji
AU - Yamada, Hiroya
AU - Ikeya, Miyuki
AU - Teshigawara, Atsushi
AU - Kageyama, Itsuki
AU - Nouchi, Yuki
AU - Wakasugi, Takuya
AU - Yamazaki, Mirai
AU - Mizuno, Genki
AU - Tsuboi, Yoshiki
AU - Ishikawa, Hiroaki
AU - Ohgami, Nobutaka
AU - Suzuki, Koji
AU - Ohashi, Koji
N1 - Publisher Copyright:
© 2023 Elsevier Inc.
PY - 2024/1/1
Y1 - 2024/1/1
N2 - Aims: The developmental origin of health and disease (DOHaD) theory postulates that poor nutrition during fetal life increases the risk of disease later in life. Excessive fructose intake has been associated with obesity, diabetes, and nonalcoholic fatty liver disease, and maternal fructose intake during pregnancy has been shown to affect offspring health. In this study, we investigated the effects of high maternal fructose intake on the liver stem/progenitor cells of offspring. Main method: A fructose-based DOHaD model was established using Sprague-Dawley rats. Small hepatocytes (SHs), which play an important role in liver development and regeneration, were isolated from the offspring of dams that were fed a high-fructose corn syrup (HFCS) diet. The gene expression and DNA methylation patterns were analyzed on postnatal day (PD) 21 and 60. Key findings: Maternal HFCS intake did not affect body weight or caloric intake, but differences in gene expression and DNA methylation patterns were observed in the SHs of offspring. Functional analysis revealed an association between metabolic processes and ion transport. Significance: These results suggest that maternal fructose intake affects DNA methylation and gene expression in the liver stem/progenitor cells of offspring. Furthermore, the prolonged retention of these changes in gene expression and DNA methylation in adulthood (PD 60) suggests that maternal fructose intake may exert lifelong effects. These findings provide insights into the DOHaD for liver-related disorders and highlight the importance of maternal nutrition for the health of the next generation.
AB - Aims: The developmental origin of health and disease (DOHaD) theory postulates that poor nutrition during fetal life increases the risk of disease later in life. Excessive fructose intake has been associated with obesity, diabetes, and nonalcoholic fatty liver disease, and maternal fructose intake during pregnancy has been shown to affect offspring health. In this study, we investigated the effects of high maternal fructose intake on the liver stem/progenitor cells of offspring. Main method: A fructose-based DOHaD model was established using Sprague-Dawley rats. Small hepatocytes (SHs), which play an important role in liver development and regeneration, were isolated from the offspring of dams that were fed a high-fructose corn syrup (HFCS) diet. The gene expression and DNA methylation patterns were analyzed on postnatal day (PD) 21 and 60. Key findings: Maternal HFCS intake did not affect body weight or caloric intake, but differences in gene expression and DNA methylation patterns were observed in the SHs of offspring. Functional analysis revealed an association between metabolic processes and ion transport. Significance: These results suggest that maternal fructose intake affects DNA methylation and gene expression in the liver stem/progenitor cells of offspring. Furthermore, the prolonged retention of these changes in gene expression and DNA methylation in adulthood (PD 60) suggests that maternal fructose intake may exert lifelong effects. These findings provide insights into the DOHaD for liver-related disorders and highlight the importance of maternal nutrition for the health of the next generation.
UR - http://www.scopus.com/inward/record.url?scp=85179066791&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85179066791&partnerID=8YFLogxK
U2 - 10.1016/j.lfs.2023.122315
DO - 10.1016/j.lfs.2023.122315
M3 - Article
C2 - 38035994
AN - SCOPUS:85179066791
SN - 0024-3205
VL - 336
JO - Life Sciences
JF - Life Sciences
M1 - 122315
ER -